At KRING, the organization brings together entrepreneurs and corporate leaders to build ventures with real impact. Former DSV CEO Jens Bjørn Andersen and former GN CEO René Svendsen-Tune have joined aescolab's board to help scale the company's mission of improving employee health through blood-biomarker analysis and personalised lifestyle recommendations.
The KRING Philosophy
KRING operates at the intersection of two distinct worlds: entrepreneurs driven by ideas and purpose, and corporate leaders seeking innovation and differentiation. The organization bridges these communities, leveraging corporate experience and networks to accelerate ventures faster than traditional paths.
Leadership Profiles
Jens Bjørn Andersen brings extensive scaling experience as a former CEO who is described as visionary, grounded, and remarkable at cutting through complexity. His involvement with aescolab combines his investor and board member roles.
René Svendsen-Tune contributes global leadership experience from CEO positions at GN, Nilfisk, and Teleca, plus executive roles at Nokia. His background emphasizes transformation, innovation, and operational excellence across large organizations.
About aescolab
Aescolab operates as an AI and human centric tech-platform analyzing over 50 biomarkers in an ISO-certified laboratory. The platform targets both individuals seeking health optimization and companies aiming to reduce employee illness-related downtime.
The Board
The aescolab board includes Thomas Refdal, Martin Haislund, and Martin Kring from KRING, alongside CEO and Co-Founder Stephan Alexander Dreier, with Andersen and Svendsen-Tune as board members and investors.
KRING concludes by emphasizing gratitude to corporate leaders who contribute strategic depth, accelerate progress, and help lift organizational ambitions.
